tm
Seeing Is Believing
tm
Seeing Is Believing
FATE is currently covered by 19 analysts with an average price target of $13.32. This is a potential upside of $8.54 (178.66%) from yesterday's end of day stock price of $4.78.
Fate Therapeutics's activity chart (see below) currently has 154 price targets and 139 ratings on display. The stock rating distribution of FATE is 46% BUY, 48% HOLD and 6% SELL.
Analysts average stock forecasts to be materialized ratio is 64.42% with an average time for these price targets to be met of 119.54 days.
Highest price target for FATE is $12, Lowest price target is $5, average price target is $13.32.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 28-Mar-2024.
Currently out of the existing stock ratings of FATE, 23 are a BUY (46%), 24 are a HOLD (48%), 3 are a SELL (6%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
6
$1.22 (25.52%)
4
26 days ago
2/3 (66.67%)
$-1.34 (-18.26%)
111
Hold
7
$2.22 (46.44%)
3
1 months 27 days ago
7/8 (87.5%)
$-0.46 (-6.17%)
153
Hold
1 months 27 days ago
7/12 (58.33%)
$48.8 (301.23%)
119
Buy
10
$5.22 (109.21%)
12
1 months 27 days ago
5/8 (62.5%)
$2.54 (34.05%)
87
Hold
7
$2.22 (46.44%)
6
1 months 27 days ago
3/6 (50%)
$-0.46 (-6.17%)
88
What is FATE (Fate Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FATE (Fate Therapeutics)?
Which analyst is the currently most bullish on FATE (Fate Therapeutics)?
Which analyst is the currently most reserved on FATE (Fate Therapeutics)?
